Woody James N.
Insider CIK 1553355 · OMED Director, 10% owner · TLOG Director · ATNF Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ATNF 180 Life Sciences Corp. | P Buy | 2023-12-15 | 2023-12-18 | 25,000 | $0.19 | $4.8K | 66,888 | SEC↗ |
| ATNF 180 Life Sciences Corp. | A Award deriv | 2023-09-04 | 2023-09-08 | 75,000 | — | $0 | 75,000 | SEC↗ |
| ATNF 180 Life Sciences Corp. | P Buy | 2023-05-18 | 2023-05-18 | 40,000 | $1.03 | $41.2K | 41,888 | SEC↗ |
| ATNF 180 Life Sciences Corp. | P Buy | 2021-12-09 | 2021-12-10 | 12,500 | $4.27 | $53.4K | 37,752 | SEC↗ |
| ATNF 180 Life Sciences Corp. | A Award deriv | 2021-02-26 | 2021-03-03 | 1,400,000 | — | $0 | 1,400,000 | SEC↗ |
| ATNF 180 Life Sciences Corp. | P Buy | 2020-11-09 | 2020-11-12 | 1,000 | $3.29 | $3.3K | 25,252 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | A Award deriv | 2015-01-28 | 2015-01-30 | 10,000 | $5.25 | $52.5K | 30,000 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | C Conversion deriv | 2013-12-17 | 2013-12-19 | 227,266 | — | $0 | 0 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | C Conversion deriv | 2013-12-17 | 2013-12-19 | 354,663 | — | $0 | 0 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | C Conversion deriv | 2013-12-17 | 2013-12-19 | 17,733 | — | $0 | 0 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | C Conversion deriv | 2013-12-17 | 2013-12-19 | 8,866 | — | $0 | 0 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | C Conversion deriv | 2013-12-17 | 2013-12-19 | 11,363 | — | $0 | 0 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | C Conversion deriv | 2013-12-17 | 2013-12-19 | 5,681 | — | $0 | 0 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | C Conversion deriv | 2013-12-17 | 2013-12-19 | 104,118 | — | $0 | 0 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | X Exercise deriv | 2013-12-17 | 2013-12-19 | 71 | — | $0 | 0 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | X Exercise deriv | 2013-12-17 | 2013-12-19 | 143 | — | $0 | 0 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | X Exercise deriv | 2013-12-17 | 2013-12-19 | 2,850 | — | $0 | 0 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | C Conversion deriv | 2013-12-17 | 2013-12-19 | 2,602 | — | $0 | 0 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | C Conversion deriv | 2013-12-17 | 2013-12-19 | 5,205 | — | $0 | 0 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | P Buy | 2013-12-17 | 2013-12-19 | 243,189 | $7.00 | $1.70M | 243,189 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | P Buy | 2013-12-17 | 2013-12-19 | 12,159 | $7.00 | $85.1K | 255,348 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | P Buy | 2013-12-17 | 2013-12-19 | 6,079 | $7.00 | $42.6K | 261,427 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | C Conversion | 2013-12-17 | 2013-12-19 | 354,663 | — | $0 | 616,090 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | C Conversion | 2013-12-17 | 2013-12-19 | 17,733 | — | $0 | 633,823 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | C Conversion | 2013-12-17 | 2013-12-19 | 8,866 | — | $0 | 642,689 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | C Conversion | 2013-12-17 | 2013-12-19 | 227,266 | — | $0 | 869,955 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | C Conversion | 2013-12-17 | 2013-12-19 | 11,363 | — | $0 | 881,318 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | C Conversion | 2013-12-17 | 2013-12-19 | 104,118 | $7.00 | $728.8K | 991,117 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | C Conversion | 2013-12-17 | 2013-12-19 | 5,205 | $7.00 | $36.4K | 996,322 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | C Conversion | 2013-12-17 | 2013-12-19 | 2,602 | $7.00 | $18.2K | 998,924 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | X Exercise | 2013-12-17 | 2013-12-19 | 2,850 | $6.40 | $18.2K | 1,001,774 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | X Exercise | 2013-12-17 | 2013-12-19 | 143 | $6.40 | $915 | 1,001,917 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | X Exercise | 2013-12-17 | 2013-12-19 | 71 | $6.40 | $454 | 1,001,988 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | C Conversion | 2013-12-17 | 2013-12-19 | 5,681 | — | $0 | 886,999 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion deriv | 2013-07-23 | 2013-07-23 | 34,649 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion deriv | 2013-07-23 | 2013-07-23 | 65,476 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion deriv | 2013-07-23 | 2013-07-23 | 426,315 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion deriv | 2013-07-23 | 2013-07-23 | 100,000 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion deriv | 2013-07-23 | 2013-07-23 | 8,947 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion deriv | 2013-07-23 | 2013-07-23 | 17,324 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion deriv | 2013-07-23 | 2013-07-23 | 279,135 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion deriv | 2013-07-23 | 2013-07-23 | 692,994 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion deriv | 2013-07-23 | 2013-07-23 | 316,079 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion deriv | 2013-07-23 | 2013-07-23 | 74,142 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion deriv | 2013-07-23 | 2013-07-23 | 15,299 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion deriv | 2013-07-23 | 2013-07-23 | 30,599 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion deriv | 2013-07-23 | 2013-07-23 | 611,995 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | P Buy | 2013-07-23 | 2013-07-23 | 1,080 | $17.00 | $18.4K | 33,703 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | P Buy | 2013-07-23 | 2013-07-23 | 2,161 | $17.00 | $36.7K | 67,409 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion | 2013-07-23 | 2013-07-23 | 34,649 | — | $0 | 65,248 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion | 2013-07-23 | 2013-07-23 | 30,599 | — | $0 | 30,599 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | P Buy | 2013-07-23 | 2013-07-23 | 43,223 | $17.00 | $734.8K | 1,348,212 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion | 2013-07-23 | 2013-07-23 | 692,994 | — | $0 | 1,304,989 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion | 2013-07-23 | 2013-07-23 | 611,995 | — | $0 | 611,995 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | P Buy | 2013-07-23 | 2013-07-23 | 33,834 | $17.00 | $575.2K | 1,055,363 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion | 2013-07-23 | 2013-07-23 | 316,079 | — | $0 | 1,021,529 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion | 2013-07-23 | 2013-07-23 | 279,135 | — | $0 | 705,450 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion | 2013-07-23 | 2013-07-23 | 426,315 | — | $0 | 426,315 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | P Buy | 2013-07-23 | 2013-07-23 | 7,937 | $17.00 | $134.9K | 247,555 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion | 2013-07-23 | 2013-07-23 | 74,142 | — | $0 | 239,618 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion | 2013-07-23 | 2013-07-23 | 65,476 | — | $0 | 165,476 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion | 2013-07-23 | 2013-07-23 | 100,000 | — | $0 | 100,000 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion | 2013-07-23 | 2013-07-23 | 8,947 | — | $0 | 30,876 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion | 2013-07-23 | 2013-07-23 | 15,299 | — | $0 | 15,299 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion | 2013-07-23 | 2013-07-23 | 17,324 | — | $0 | 32,623 | SEC↗ |